Moderna Inc

NASDAQ:MRNA   3:59:59 PM EDT
123.70
-0.62 (-0.50%)
Products, Regulatory

Moderna Seeks U.S. Authorization Of Omicron-Targeting Bivalent COVID Booster Vaccine

Published: 08/23/2022 21:13 GMT
Moderna Inc (MRNA) - Moderna Completes Application to U.S. Food and Drug Administration for Emergency Use Authorization of Omicron-targeting Bivalent Covid-19 Booster Vaccine, Mrna-1273.222.
Moderna Inc - Pending Authorization, Moderna Ready to Ship Bivalent Booster Mrna-1273.222 in September.
Moderna Inc - Clinical Data Available for Moderna's Bivalent Covid-19 Booster Vaccines Have Met All Primary Endpoints and Support Request for Eua.
Moderna Inc - Phase 2/3 Trial for Mrna-1273.222 is Currently Underway.